Model Organisms in Cancer Research-Powers and Limitations

Ravi Adusumalli

Abstract


Background: Cancer is a term that is used to describe a wide range of diseases, but they all have some characteristics in common. The goal of this review is to highlight the most commonly used cancer models as well as their role in tumor biology. Although each model has inherent powers and limitations in faithfully mirroring the complexity of tumorigenesis, there is no perfect single model for cancer. Main body: Oncologists can learn about the tumor microenvironment, gene mutations, and complex physiological systems using model organisms for cancer research. The widespread use of model organisms in cancer research has greatly improved understanding of how mutations in humans lead to cancer. Human cancer cell lines, drosophila, yeast, and mice are among the model organisms used to study cancer. However, these model organisms have flaws that can cause the tumor microenvironment to be falsified and restrict the defined targets in translational studies. Conclusion: The overwhelming message from various animal models allows us to better understand the state of the disease and develop new cancer treatments. Mice are a good substitute and surrogate for patients in the evaluation of diagnosis and prognosis among the various model organisms used in cancer research.

Keywords


Animal Models, Cancer, Tumorigenesis

Full Text:

PDF

References


H, P., . Science and Society, 2008. 9(8): p. pp 699-818.

Louise. W, From model Organism to medical advances. Science in School, Spring 2014(28): p. 18-21.

Cheon, D.J. and S. Orsulic, Mouse models of cancer. Annu Rev Pathol, 2011. 6: p. 95-119.

de Jong, M. and T. Maina, Of mice and humans: are they the same?--Implications in cancer translational research. J Nucl Med, 2010. 51(4): p. 501-4.

Vernon ES, R.A., Richard CM, Preclinical animal models for the development of cancer chemoprevention drugs. Cancer drug discovery and development, 2005: p. pp 39-46.

Cekanova, M. and K. Rathore, Animal models and therapeutic molecular targets of cancer: utility and limitations. Drug Des Devel Ther, 2014. 8: p. 1911-21.

Kim, J., B.-K. Koo, and J.A. Knoblich, Human organoids: model systems for human biology and medicine. Nature Reviews Molecular Cell Biology, 2020. 21(10): p. 571-584.

C.P. Kashyap, B.T., Shikka. S, Sweta. K, Priti. V, Swati. S and Vikranth. A, Human cancer cell lines- A brief communication. J. Chem. Pharm. Res.,, 2011. 3(6): p. 514-520.

Tomaszek, S. and D.S. Tomaszek, Cell Lines, Tissue Samples, Model Organisms, and Biobanks: Infrastructure and Tools for Cancer Systems Biology. 2011: p. 127-152.

Miles, W.O., N.J. Dyson, and J.A. Walker, Modeling tumor invasion and metastasis in Drosophila. Dis Model Mech, 2011. 4(6): p. 753-61.

Bier, E., Drosophila, the golden bug, emerges as a tool for human genetics. Nat Rev Genet, 2005. 6(1): p. 9-23.

Becher, O.J. and E.C. Holland, Genetically engineered models have advantages over xenografts for preclinical studies. Cancer Res, 2006. 66(7): p. 3355-8, discussion 3358-9.

Cheng, L., et al., Mouse models for cancer stem cell research. Toxicol Pathol, 2010. 38(1): p. 62-71.

Ferreira, D., F. Adega, and R. Chaves, The Importance of Cancer Cell Lines as in vitro Models in Cancer Methylome Analysis and Anticancer Drugs Testing. 2013.

David B, S.A.C., and Cherry J.M,, Yeast as a Model Organism. Science 1997. 277(5330): p. 1259-1260.

Frese, K.K. and D.A. Tuveson, Maximizing mouse cancer models. Nat Rev Cancer, 2007. 7(9): p. 645-58.




DOI: http://dx.doi.org/10.7575/aiac.abcmed.v.9n.2p.1

Refbacks

  • There are currently no refbacks.




Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

2013-2022 (CC-BY) Australian International Academic Centre PTY.LTD.

Advances in Bioscience and Clinical Medicine